Business
Hugel reports record Q1 earnings, driving strong global growth in aesthetics
Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has delivered record consolidated results for the first quarter. On Thursday, the company reported net sales of KRW116.6 billion, operating profit of KRW47.6 billion, and net profit of KRW40.6 billion for the January–March period this year, representing on-year increases of 29.9%, 22.3%, and 31.5%, respectively.
About this update from Hugel, Inc.
[{"type":"text","content":"- Net sales and operating profit reach KRW116.6 billion and KRW47.6 billion, up 29.9% and 22.3% on-year, respectively; net profit rises to KRW40.6 billion, up 31.5%- Strong global growth amid stable domestic market; toxin and dermal filler overseas sales rise 46% on-year","length":272,"tagName":"p"},{"type":"text","content":"SEOUL, South Korea, May 7, 2026 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has delivered record consolidated results for the first quarter. On Thursday, the company reported net sales of KRW116.6 billion, operating profit of KRW47.6 billion, and net profit of KRW40.6 billion for the January–March period this year, representing on-year increases of 29.9%, 22.3%, and 31.5%, respectively.","length":449,"tagName":"p"},{"type":"image","alt":"Hugel Inc. (PRNewsfoto/Hugel)","displaySize":"","headline":null,"caption":"Hugel Inc. (PRNewsfoto/Hugel)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/5b783c434ec9665b85cfc00708bc4612"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lVSkorf67i40k3OsG3go3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNQ--/https://media.zenfs.com/en/prnewswire.com/5b783c434ec9665b85cfc00708bc4612","width":400,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/YbZzyW68Fe51HqPrSBYaTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MA--/https://media.zenfs.com/en/prnewswire.com/5b783c434ec9665b85cfc00708bc4612","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2682421/HUGEL_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The solid results were primarily fueled by global growth, supported by stable performance in Korea. Combined net sales from these two core categories reached KRW70.8 billion, up 46% on-year. In particular, net sales in the company's four key markets, the U.S., China, Europe, and Brazil, totaled KRW21 billion.","length":314,"tagName":"p"},{"type":"text","content":"Combined domestic net sales of toxin and dermal fillers reached KRW26.7 billion, maintaining solid growth despite intensifying competition in the Korean aesthetics market. This performance was driven by expanded seminars for healthcare professionals and a strong focus on medical marketing activities. Hugel also secured...